Sarcoma patients were divided into two groups based on the distribution of risk scores, survival status, and expression of EIF4G3 and WDR4 (Supplementary Figures S3C, D) and the risk score = (0.1036)*EIF4G3 + (0.5255)*WDR4 was applied to the calculation of DSS. This evidence concerns the gene EIF4G3 and sarcoma.